Ra Medical Systems (NYSE:RMED) announced today that it enrolled 100 subjects in a pivotal trial for its Dabra excimer laser system. Carlsbad, California-based Ra Medical’s pivotal trial will evaluate the safety and effectiveness of Dabra as an atherectomy device for treating peripheral arterial disease (PAD). The study aims to enroll up to 125 subjects. The […]
Ra Medical
Ra Medical closes $12.1M offering
Ra Medical Systems (NYSE:RMED) announced today that it closed its previously announced $12.1 million public offering. Carlsbad, California-based Ra Medical last week confirmed the pricing of the public offering but did not specify its intended use of proceeds. The company, which develops an excimer laser system for treating vascular diseases, offered more than 9.5 million […]
Ra Medical prices $12M offering
Ra Medical Systems (NYSE:RMED) announced today that it priced an underwritten public offering worth proceeds of approximately $12 million. Carlsbasd, California-based Ra Medical, a developer of an excimer laser system for treating vascular diseases, did not provide an intended use for the proceeds. According to a news release, the offering includes more than 9.5 million […]
MedTech 100 roundup: On the rise again
After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]
Strata Skin Sciences buys Ra Medical’s Pharos dermatology business
Strata Skin Sciences (NSDQ:SSKN) announced that it acquired the Pharos dermatology business from Ra Medical (NYSE:RMED). Horsham, Pa.-based Strata can now market its full business solution to Ra Medical’s existing customer base comprised of 400 dermatology practices, offering opportunities to increase its recurring revenue base and a pathway to gain additional placements for its XTRAC […]
Ra Medical threatened with stock exchange delisting
Ra Medical Systems (NYSE:RMED) announced today that it received notice that is is no longer in compliance with the New York Stock Exchange’s listing standards. The Carlsbad, Calif.-based company learned that it is not complying with the NYSE continued listing standard that requires companies to maintain an average closing share price of at least $1 over […]
Ra Medical Systems prices $10m public offering
Ra Medical Systems (NYSE:RMED) announced today that it priced a public offering of its common stock with gross proceeds expected to reach approximately $10 million. The Carlsbad, Calif.-based company is offering more than 22.2 million shares of common stock (or common stock equivalents) with accompanying warrants to purchase up to 22.2 million shares of common stock, […]
Ra Medical Systems appoints new CEO
Ra Medical Systems (NYSE:RMED) this week said it appointed Will McGuire as CEO, effective March 30. Andrew Jackson has served as interim CEO since August and will remain as the company’s chief financial officer. “Will’s extensive industry experience, particularly in the vascular space, makes him an ideal fit to lead Ra Medical,” chairman Martin Colombatto said […]
NYSE accepts Ra Medical’s compliance plan
Ra Medical Systems (NYSE:RMED) announced today that the New York Stock Exchange (NYSE) accepted its business plan to regain compliance with the NYSE continued listing standards. In December 2019, Carlsbad, Calif.-based Ra Medical Systems received a letter from the NYSE to notify the company of its non-compliance with the NYSE continued listing standards, as Ra Medical’s […]
Ra Medical Systems wins FDA’s OK to study new uses for Dabra system
Ra Medical Systems (NYSE:RMED) announced today that it won investigational device exemption approval to study use of its Dabra excimer laser system as an atherectomy device to treat peripheral vascular stenoses. The Dabra system is designed to destroy arteriosclerotic blockages through the use of radiation ablation. The system won FDA 510(k) clearance in May 2017 for the […]
Ra Medical appoints VP of engineering
Ra Medical Systems (NYSE:RMED) today said it appointed Chris Folk as VP of engineering, effective Jan. 13. Folk has more than 20 years of engineering experience in medtech and has led a number of design, development and engineering initiatives of medical devices. He will report directly to interim CEO and chief financial officer Andrew Jackson. “Chris […]
